Tilray Couldn’t Win Alone

Hilary Kramer

Hilary Kramer is an investment analyst and portfolio manager with 30 years of experience on Wall Street.

All year, my core argument against Big Cannabis revolved around the crowd of “me too” cultivators sitting on just enough of the market to block stronger rivals from succeeding.

The underlying business opportunity wasn’t a stumbling block. Demand for legal cannabis remains as robust as ever, making a lot of street-level entrepreneurs rich.

The problem was simply too many companies at the top of the food chain with billions of dollars to spend chasing world-changing ambition. One or two can achieve great things. Four or five get in each other’s way.

And that’s why I think Tilray Corp. (NASDAQ:TLRY) never really found its footing within the cannabis landscape. The business plan didn’t point anywhere beyond a dead end.

Ultimately, its leaders recognized that their company just lacked the sizzle to stand out on Wall Street or the scale to dominate the space. They did the smart thing and started talking to one of their top competitors about joining forces.

That competitor was Aphria Inc. (NASDAQ:APHA), probably my favorite Big Cannabis stock by virtue of its leadership in the mature but static medicinal marijuana segment. Aphira’s management heard Tilray’s case and agreed that they could go a lot farther together than they could on their own.

Say hello to the new Tilray, which is really about 60% Aphria, rolled into one $4 billion entity selling about 20% of the world’s cannabis. Think of it as Tilray selling itself to a bigger and more dynamic competitor.

The main things Aphria’s leaders are keeping are the Wall-Street-friendly name and the existing sales contracts. It is a long way down for Tilray investors, who collectively owned a company worth $20 billion at its peak.

Tilray investors are minority shareholders now. But at least their combined company has a shot at achieving something now.

And the industry can breathe a little easier. One less giant reduces confusion and waste. My only question is whether Aphria can achieve its goals faster now that it’s tied to Tilray.

Until we see proof of that, I’m sticking with the small Cannabis 2.0 companies eager to change all the rules. 

We’re now deep in the green in my IPO Edge, where a tiny cannabis stock has earned us 33% so far this month. I’d rather be in that company than all of Big Cannabis put together.

Like This Article?
Now Get Mark's FREE Special Report:
3 Dividend Plays with Sky-High Returns

This newly-released report by a top-20 living economist details three investments that are your best bets for income and appreciation for the rest of the year and beyond.

Get Access to the Report, 100% FREE


img
previous article

“Today’s version of ‘buy low, sell high’ is: Buy high, sell higher. Stocks that are high and going higher are a good buy. Stocks that are ‘cheap’ and getting cheaper don’t interest me.” --Gerald Loeb, "Battle for Investment Survival" I quote veteran investor Gerald Loeb on p. 37 in the new 10th-anniversary edition of “The Maxims of Wall Street,” and his advice is very relevant. His motto is “buy high, sell higher,” which pe

PREMIUM SERVICES FOR INVESTORS

Dr. Mark Skousen

Named one of the "Top 20 Living Economists," Dr. Skousen is a professional economist, investment expert, university professor, and author of more than 25 books.

Product Details

LEARN MORE HERE

Bryan Perry

A former Wall Street financial advisor with three decades' experience, Bryan Perry focuses his efforts on high-yield income investing and quick-hitting options plays.

Product Details

LEARN MORE HERE

Jim Woods

Jim Woods has over 20 years of experience in the markets from working as a stockbroker,
financial journalist, and money manager. As well as a book author and regular contributor to
numerous investment websites, Jim is the editor of:

Product Details

LEARN MORE HERE

Bob Carlson

Bob Carlson provides independent, objective research covering all the financial issues of retirement and retirement planning. In addition, Bob serves as Chairman of the Board of Trustees of the Fairfax County (VA) Employees’ Retirement System, which has over $2.8 billion in assets.

Product Details

LEARN MORE HERE

Hilary Kramer

Hilary Kramer is an investment analyst and portfolio manager with 30 years of experience on Wall Street. Since 2010, Hilary's financial publications have provided stock analysis and investment advice to her subscribers:

Product Details

LEARN MORE HERE

Jon Johnson

Jon Johnson's philosophy in investing and trading is to take what the market gives you regardless if that is to the upside or downside. For the past 21 years, Jon has helped thousands of clients gain success in the financial markets through his newsletters and education services:

Product Details

LEARN MORE HERE

DividendInvestor.com

Used by financial advisors and individual investors all over the world, DividendInvestor.com is the premier provider and one-stop shop for dividend information and research.

Product Details

Popular tools include our proprietary Dividend Calendar, Dividend Calculator, Dividend Score Card, and many more.

LEARN MORE HERE